Volume 7: Issue 4

The scientific program of the Pulmonary Hypertension Association is guided by the association's Scientific Leadership Council. The Council includes the following health care professionals:

Vallerie V. McLaughlin, MD, SLC Chair, University of Michigan Health System, Ann Arbor, Michigan
David B. Badesch, MD, SLC Immediate Past Chair, University of Colorado Health Sciences Center, Denver, Colorado
John H. Newman, MD, SLC Chair Elect, Vanderbilt Medical School, Nashville, Tennessee
Robyn J. Barst, MD, New York, New York
Raymond L. Benza, MD, University of Alabama Health System, Birmingham, Alabama
Todd Bull, MD, University of Colorado Health Sciences Center,

Robert P. Frantz, MD

Download as Powerpoint
Download Figure

Barbro Kjellstrom, PhD

Download as Powerpoint
Download Figure

Michael McGoon, MD

Download as Powerpoint
Download Figure

Although an abnormality of pulmonary hemodynamics is the defining characteristic of pulmonary hypertension (PH), there is considerable debate about the optimal method of assessing pulmonary arterial pressure (PAP). Cardiac catheterization is widely accepted as the most accurate and comprehensive technique for measuring PAP and venous pressure. Doppler echocardiography provides a high level of correlation with invasively measured hemodynamics and is free of risk or significant discomfort.

Both of these methods have particular advantages and each has an

This discussion was moderated by Ronald J. Oudiz, MD, Associate Professor of Medicine, UCLA School of Medicine and Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California. Participants included: Hunter C. Champion, MD, PhD, Assistant Professor, Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Robert Naeije, MD, PhD, Professor and Chairman of the Department of Physiology and Pathophysiology at Erasme University Hospital, Brussels, Belgium; Virginia D. Steen, MD, Professor of Medicine and Director of the Rheumatology Fellowship Program, Georgetown University School of Medicine, Washington, DC; and David Systrom, MD, Director, Cardiopulmonary Exercise Lab, Department of Medicine, Pulmonary Critical Care, Massachusetts General Hospital, Boston, Massachusetts.

A Definitive Guide to New Applications in Diagnosis

Editor's Memo

The Scientific Leadership Council of the Pulmonary Hypertension Association

John Newman, MD, Tracks Pathogenesis of PH, From Exercise-Related Factors to Emerging Evidence on the Role of the Metabolic Syndrome

The Role of Echocardiography in the Diagnosis and Assessment of Pulmonary Hypertension

Cardiopulmonary Hemodynamics in Pulmonary Hypertension: Pressure Tracings, Waveforms, and More

Role of Cardiac MRI in Pulmonary Hypertension

Ambulatory Hemodynamic Monitoring in Pulmonary Arterial Hypertension

Controversies and Consensus: Identifying the Key Issues in Exercise Testing

International Corner

A Meeting of Minds From Around the World

Conference Abstracts

Guest Editor’s Memo

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension

Editor’s Memo

Pulmonary Hypertension Associated With Parenchymal Lung Disease